Abstract | PURPOSE OF REVIEW:
Metabolic syndrome is continuously increasing among the world's populations. Metabolic syndrome is a medical condition in which individuals suffer from high blood pressure, high blood glucose levels, and obesity. The in vitro and in vivo bioactivities of dairy milk protein-derived peptides ( MPDP) have proven their potential as an excellent natural alternative to the current medical treatment for metabolic syndrome. In this context, the review discussed the major protein source of dairy milk and provides current knowledge on the novel and integrated approach to MPDP production. A detailed comprehensive discussion is provided on the current state of knowledge regarding the in vitro and in vivo bioactivities of MPDP against metabolic syndrome. In addition, the most important aspect of digestive stability, allergenicity, and further directions for MPDP application is provided. RECENT FINDINGS:
|
Authors | Pankaj Koirala, Merina Dahal, Sampurna Rai, Milan Dhakal, Nilesh Prakash Nirmal, Sajid Maqsood, Fahad Al-Asmari, Athisaya Buranasompob |
Journal | Current nutrition reports
(Curr Nutr Rep)
Vol. 12
Issue 2
Pg. 308-326
(06 2023)
ISSN: 2161-3311 [Electronic] United States |
PMID | 37204636
(Publication Type: Journal Article, Review)
|
Copyright | © 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. |
Chemical References |
- Milk Proteins
- Peptides
- Caseins
|
Topics |
- Humans
- Animals
- Milk Proteins
(pharmacology, metabolism)
- Metabolic Syndrome
(drug therapy)
- Peptides
(pharmacology, metabolism)
- Milk
(metabolism)
- Caseins
(metabolism)
|